Seto Yoshiki, Ohtake Hiroto, Kato Masashi, Onoue Satomi
Department of Pharmacokinetics and Pharmacodynamics, School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka, Japan.
Department of Pharmacokinetics and Pharmacodynamics, School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka, Japan
J Pharmacol Exp Ther. 2015 Aug;354(2):195-202. doi: 10.1124/jpet.115.223644. Epub 2015 May 27.
This study aimed to qualify photosafety screening on the basis of photochemical and pharmacokinetic (PK) data on dermally applied chemicals. Six benzophenone derivatives (BZPs) were selected as model compounds, and in vitro photochemical/phototoxic characterization and dermal cassette-dosing PK study were carried out. For comparison, an in vivo phototoxicity test was also conducted. All of the BZPs exhibited strong UVA/UVB absorption with molar extinction coefficients of over 2000 M(-1) × cm(-1), and benzophenone and ketoprofen exhibited significant reactive oxygen species (ROS) generation upon exposure to simulated sunlight (about 2.0 mW/cm(2)); however, ROS generation from sulisobenzone and dioxybenzone was negligible. To verify in vitro phototoxicity, a 3T3 neutral red uptake phototoxicity test was carried out, and benzophenone and ketoprofen were categorized to be phototoxic chemicals. The dermal PK parameters of ketoprofen were indicative of the highest dermal distribution of all BZPs tested. On the basis of its in vitro photochemical/phototoxic and PK data, ketoprofen was deduced to be highly phototoxic. The rank of predicted phototoxic risk of BZPs on the basis of the proposed screening strategy was almost in agreement with the results from the in vivo phototoxicity test. The combined use of photochemical and cassette-dosing PK data would provide reliable predictions of phototoxic risk for candidates with high productivity.
本研究旨在根据经皮肤应用化学品的光化学和药代动力学(PK)数据对光安全性筛选进行鉴定。选择六种二苯甲酮衍生物(BZPs)作为模型化合物,并进行了体外光化学/光毒性表征和皮肤盒式给药PK研究。为作比较,还进行了体内光毒性试验。所有BZPs均表现出强烈的UVA/UVB吸收,摩尔消光系数超过2000 M(-¹)×cm(-¹),二苯甲酮和酮洛芬在暴露于模拟阳光(约2.0 mW/cm²)时产生显著的活性氧(ROS);然而,舒利苯酮和二羟基苯甲酮产生的ROS可忽略不计。为验证体外光毒性,进行了3T3中性红摄取光毒性试验,二苯甲酮和酮洛芬被归类为光毒性化学品。酮洛芬的皮肤PK参数表明其在所有测试BZPs中的皮肤分布最高。根据其体外光化学/光毒性和PK数据,推断酮洛芬具有高光毒性。基于所提出的筛选策略预测的BZPs光毒性风险等级几乎与体内光毒性试验结果一致。光化学和盒式给药PK数据的联合使用将为具有高生产力的候选物提供可靠的光毒性风险预测。